Project Grant W911QY1710001

The U.S. Department of the Army awarded a $275,000 Project Grant to Bio-Gene Technology Limited (UEI: NXXJZ1CHKH45) under the Pest Management and Vector Control Research program (CFDA 12.355) to support research and development efforts for the development of multi-use controlled release devices (MUW-CRDs) based on the delivery of flavocide as a next-generation protection system for controlling flying insect vectors. The 3-year grant period runs from January 10, 2025 to January 10, 2028. The Pest...

This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund research to identify powerful mosquito repellents that target olfaction, gustation, and sodium channels. The $506,842 award to the Regents of the University of California at Riverside, effective December 16, 2024 through November 30, 2029, aims to develop safe, affordable, and...

This $505,238 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to identify and characterize skin-associated compounds that can alter mosquito landing and feeding behavior. The overarching goal is to develop improved topical mosquito repellents by leveraging mosquitoes' olfactory and gustatory (taste) systems. The research will validate...

This $606,815 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Duquesne University aims to engineer paratransgenic bacterial strains that can interfere with the ability of mosquitoes to transmit malaria parasites. Specifically, the project will leverage expertise in bacterial genetics and vector microbial ecology to develop paratransgenic strains of Asaia bogorensis that have no antibiotic...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $211,038 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Johns Hopkins University to target a reductive dehalogenase enzyme as a new strategy for controlling mosquito populations. The research aims to investigate how this enzyme protects insects like fruit flies and mosquitoes from the accumulation of endogenous halotyrosines, which can suppress fertility. The project will examine the role...

This $649,972 federal Project Grant award from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) Small Business Innovation Research (SBIR) Program supports the development of textile coating systems that incorporate biobased insect repellents. The grantee, Insectapel LLC, is a for-profit limited liability company focused on creating innovative, environmentally-friendly alternatives to synthetic chemical insect repellents. The research aims to leverage...

This $707,696 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify volatile organic compounds in human scent signatures that modulate attractiveness to the African malaria mosquito Anopheles gambiae, a primary vector for malaria transmission in sub-Saharan Africa. The research aims to characterize the contribution of the human skin microbiome to these scent signatures...

Farmsense, Inc. received a $275,000 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program. The award supports the development of an automated, digital classification and counting system for mosquitoes to enable more effective vector control. The project aims to create an end-to-end digital platform for mosquito surveillance that can support the work of vector control districts. The platform will leverage real-time insect...

The National Science Foundation awarded a $500,000 Project Grant to the University of Washington under the Biological Sciences federal grant program (CFDA 47.074) to investigate olfactory learning and neuromodulation in the Aedes aegypti mosquito from June 1, 2023 to May 31, 2026. The research aims to understand how odor learning modifies mosquitoes' biting behaviors through three objectives: testing whether mosquitoes only learn certain odors corresponding to antennal lobe glomeruli tuning;...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $760,318 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis to develop recombinant enhanced antiviral sensors (REAVRS) that can broadly inhibit a range of viruses to control vector-borne and zoonotic viral diseases. The project aims to generate and optimize REAVR proteins, identify and characterize virus-inducible promoters in mosquito cells,...